Tetragonia tetragonioides (New Zealand Spinach)

Tetragonia tetragonioides, commonly called New Zealand spinach, contains bioactive flavonoids, saponins, and oxalate-bound minerals that interact with glial cell signaling pathways in the prefrontal cortex. Preliminary animal research suggests these compounds may support mood regulation and hormonal balance by modulating neuroinflammatory and hypothalamic-pituitary-gonadal axis activity.

Category: Vegetable Evidence: 2/10 Tier: Emerging
Tetragonia tetragonioides (New Zealand Spinach) — Hermetica Encyclopedia

Origin & History

Tetragonia tetragonioides (New Zealand spinach) is a halophytic plant native to Asian-Pacific regions including New Zealand and Australia, belonging to the Aizoaceae family. It is classified as a USDA nutrient-dense dark leafy green vegetable, with extracts typically prepared as 70% ethanol extracts or powders from aerial parts for research purposes.

Historical & Cultural Context

TTK has been traditionally used in Asian-Pacific regions for digestive issues and as a nutrient-dense food source. In Korean traditional medicine, it is employed with formulations like JakYakGamCho-Tang for women's health, inflammation, and metabolic support, particularly in estrogen-deficient conditions.

Health Benefits

• May support mood and reduce depressive symptoms by restoring glial cell function in the prefrontal cortex (preliminary evidence from mouse studies)
• Shows potential for managing PCOS symptoms by reducing testosterone and luteinizing hormone levels (preliminary evidence from rat models)
• May help regulate androgen production and reduce ovarian cysts in hormonal imbalances (preliminary evidence from animal and cell studies)
• Traditional use suggests benefits for digestive issues and inflammatory conditions (traditional evidence only)
• Demonstrates potential anti-obesity effects in high-fat diet models (preliminary animal evidence)

How It Works

Bioactive constituents in Tetragonia tetragonioides, including flavonoids and saponins, appear to restore glial cell morphology and function in the prefrontal cortex, which is implicated in mood regulation and stress response. In models of PCOS, the plant's phytochemicals are hypothesized to suppress hypothalamic GnRH pulsatility, thereby reducing pituitary luteinizing hormone (LH) secretion and downstream ovarian androgen synthesis. Antioxidant polyphenols may also reduce oxidative stress-driven inflammation in gonadal tissue, contributing to lower circulating testosterone levels.

Scientific Research

Current evidence for Tetragonia tetragonioides is limited to preclinical animal and in vitro studies, with no human clinical trials identified. Key studies include a mouse depression model (PMID: 33628324) showing reduced depressive behaviors with 100-300 mg/kg doses, and a PCOS rat model (PMID: 29757997) demonstrating hormonal regulation with 250-500 mg/kg doses.

Clinical Summary

Current evidence for Tetragonia tetragonioides is limited to preclinical animal studies, with no completed human clinical trials published as of 2024. Mouse studies examining depressive-like behavior demonstrated that oral administration of the plant extract restored prefrontal cortex glial cell density and improved performance in forced swim and sucrose preference tests. Separate rat model studies of experimentally induced PCOS reported statistically significant reductions in serum testosterone and LH levels following extract supplementation, though exact dosages and sample sizes were small (typically n=8–12 per group). The overall evidence base is preliminary, and extrapolation to human clinical outcomes requires caution until randomized controlled trials are conducted.

Nutritional Profile

Per 100 g raw: Energy ~14–18 kcal; Water ~94 g; Protein ~1.5 g; Fat ~0.2 g; Carbohydrates ~2.5–3.0 g (Dietary fiber ~1.0–1.4 g, Sugars ~0.3 g). Vitamins: Vitamin A (as beta-carotene) ~3,500–4,400 IU (~260–310 µg RAE); Vitamin C ~30–40 mg (moderate bioavailability, may decrease significantly with cooking); Vitamin K ~250–350 µg (fat-soluble, bioavailability enhanced with dietary fat); Folate (B9) ~10–15 µg; Riboflavin (B2) ~0.13 mg; Niacin (B3) ~0.4 mg; Thiamine (B1) ~0.03 mg. Minerals: Potassium ~130–160 mg; Calcium ~40–60 mg (bioavailability reduced by oxalate content); Magnesium ~30–40 mg; Phosphorus ~25–35 mg; Iron ~0.7–1.2 mg (non-heme; bioavailability ~5–12%, enhanced by co-consumption of vitamin C); Sodium ~200–320 mg (notably higher than many leafy greens); Zinc ~0.3–0.5 mg; Manganese ~0.5–0.8 mg; Copper ~0.03–0.05 mg. Bioactive compounds: Oxalic acid ~320–800 mg/100 g (acts as antinutrient, chelates calcium and iron; blanching/boiling reduces oxalate content by 30–50%); Beta-carotene ~1,500–2,600 µg (lipophilic, bioavailability improved with fat); Lutein and zeaxanthin ~1,000–2,500 µg (carotenoids beneficial for eye health); Chlorophyll (present but not precisely quantified); Phenolic acids and flavonoids including quercetin derivatives and kaempferol glycosides (total phenolics ~50–120 mg GAE/100 g, contributing to antioxidant capacity); Betalain-like pigments in trace amounts; Phytosterols (trace, including beta-sitosterol); Saponins (minor amounts detected). Notable characteristics: High sodium-to-potassium ratio compared to conventional spinach (Spinacia oleracea); relatively salt-tolerant species, which contributes to mineral accumulation. Contains mucilaginous compounds contributing to texture. The high oxalate content is the primary antinutritional factor—cooking in boiling water and discarding the water is recommended to improve mineral bioavailability.

Preparation & Dosage

Animal studies have used oral TTK powder at 100-300 mg/kg daily for depression models and 70% ethanol extract at 250-500 mg/kg daily for PCOS models. No human dosage data is available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other dark leafy greens, adaptogenic herbs for mood support, spearmint for hormonal balance, berberine for metabolic support, vitamin D for hormone regulation

Safety & Interactions

New Zealand spinach contains moderate levels of oxalic acid, which can bind dietary calcium and contribute to kidney stone formation in susceptible individuals; those with a history of calcium oxalate urolithiasis should limit intake. High oxalate content may also reduce iron and calcium bioavailability, potentially interacting with iron supplementation or calcium-dependent medications. No formal drug interaction studies exist, but the plant's hypothesized GnRH-suppressing activity warrants caution in individuals using hormonal therapies, fertility medications such as clomiphene, or gonadotropin-based treatments. Pregnant and breastfeeding women should avoid concentrated extracts due to the absence of safety data, though culinary consumption at typical food quantities is generally regarded as safe.